Neutralization of the anticoagulant activity of low molecular weight heparin LU 47311 (Clivarin) in man by protamine chloride.

[1]  J. Fareed,et al.  Neutralization of the antithrombotic effects of heparin and Fraxiparin by protamine sulfate. , 1992, Thrombosis research.

[2]  J. Fareed,et al.  Ex vivo activity of heparin is not predictive of blood loss after neutralization by protamine. , 1992, Thrombosis research.

[3]  J. T. ten Cate,et al.  Partial in vivo neutralisation of plasma anticoagulant effects of Lomoparan (Org 10172) by protamine chloride. , 1991, Thrombosis research.

[4]  J. Wadström,et al.  Closure of the abdominal wall; how and why? Clinical review. , 1990, Acta chirurgica Scandinavica.

[5]  J. Hirsh,et al.  Hemorrhagic doses of heparin and other glycosaminoglycans induce a platelet defect. , 1986, Thrombosis research.

[6]  D. Bergqvist,et al.  Heparin and its low molecular weight derivatives: anticoagulant and antithrombotic properties. , 1986, Haemostasis.

[7]  W. Rock,et al.  In vitro aggregation of normal platelets: a hypothetical first-approximation model for light extinction in platelet-rich plasma. , 1986, Haemostasis.

[8]  J. Walenga,et al.  Biochemical and Pharmacologic Studies on the Protamine Interactions with Heparin, Its Fractions and Fragments , 1985, Seminars in thrombosis and hemostasis.

[9]  A. Gnasso,et al.  Inhibition of low molecular weight heparin by protamine chloride in vivo. , 1985, Thrombosis research.

[10]  A. Hubbard,et al.  Neutralisation of Heparan Sulphate and Low Molecular Weight Heparin by Protamine , 1985, Thrombosis and Haemostasis.

[11]  M. Lie,et al.  Assay of heparin in plasma using a chromogenic substrate for activated factor X. , 1976, Thrombosis research.

[12]  G. Born,et al.  Aggregation of Blood Platelets by Adenosine Diphosphate and its Reversal , 1962, Nature.